|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2900 USD | -7.17% |
|
-13.20% | -75.32% |
| 07-17 | BioRestorative Therapies, Inc. Announces CEO Changes, Effective July 13, 2026 | CI |
| 07-17 | BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026 | CI |
Company Valuation: BioRestorative Therapies, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 7.389 | - | - |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -29.16% | - | - |
| Enterprise Value (EV) | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 7.389 | 7.389 | 7.389 |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -29.16% | 0% | 0% |
| P/E | -0.12x | -0.54x | -0.51x | -1.23x | -0.74x | -0.59x | -0.72x | -0.71x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | -0x | 0x | 0x | -0.58x |
| Capitalization / Revenue | 330x | 84.3x | 56.2x | 24.7x | 29x | 5.26x | 3.2x | 2.36x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 5.26x | 3.2x | 2.36x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.54x | -0.47x | -0.41x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -37.3 | -5.11 | -3.42 | -1.16 | -1.58 | -0.495 | -0.405 | -0.41 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.046 | 0.1198 | 0.1458 | 0.401 | 0.3597 | 1.405 | 2.312 | 3.125 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -26.31 | -18.97 | -15.22 | -11.56 | -15.65 | -13.61 | -15.67 | -17.97 |
| Net income 1 | -44.3 | -18.49 | -14.42 | -8.979 | -14.24 | -13.52 | -15.56 | -17.83 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 4.3400 | 2.7500 | 1.7399 | 1.4300 | 1.1750 | 0.2900 | 0.2900 | 0.2900 |
| Nbr of stocks (in thousands) | 3,493 | 3,674 | 4,707 | 6,920 | 8,876 | 25,478 | - | - |
| Announcement Date | 30/03/22 | 27/03/23 | 01/04/24 | 28/03/25 | 26/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59x | - | - | - | 7.39M | |
| 33.56x | 8.36x | 25.84x | 0.05% | 57.28B | |
| 20.68x | 6.37x | 13.94x | 1.54% | 54.99B | |
| -41.86x | 13.29x | -39.17x | -.--% | 23.18B | |
| -17.88x | 4.15x | -7.26x | -.--% | 22.59B | |
| 25.74x | 5.04x | 13.35x | -.--% | 20.46B | |
| 24.54x | 4.77x | 15.5x | -.--% | 17.56B | |
| -523.64x | 37.41x | -1539.29x | -.--% | 15.67B | |
| 43.58x | 17.61x | 45.34x | 0.08% | 14.46B | |
| 17.42x | 5.04x | 11.77x | -.--% | 13.92B | |
| Average | -41.84x | 11.34x | -162.22x | 0.19% | 24.01B | |
| Weighted average by Cap. | -19.52x | 9.70x | -89.86x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRTX Stock
- Valuation BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
